NewGenIvf Group Ltd

Snapshot

NewGenIvf is a Bangkok-based fertility-services micro-cap whose FY 2025 revenue fell 13% to $4.7M, with an operating loss of $10.7M.

What's Happening Right Now

• Wed 7th Oct '26 · Earnings: For the six months ended June 30, 2026, the company reported an $8.08M net loss (versus a prior-year profit), a new $6.88M repurchase liability, and just $1.02M in cash, which it called balance-sheet stress.
• Wed 7th Oct '26 · Reverse split: NewGenIvf executed another 1-for-4 reverse stock split effective October 12, 2026, its sixth in the past year, cutting shares outstanding from about 35.7M to 8.9M to address Nasdaq's minimum bid price rule.
• Wed 30th Sep '26 · Dilutive offering: On September 30, 2026 NewGenIvf priced a $1.25M offering at $0.07 per share, a roughly 80% discount to the prior close, with pre-funded warrants that could expand Class A shares from about 2.78M to 20.6M; the filing again cites going-concern language.
• Wed 30th Sep '26 · Offering: Raised $1.25M in gross proceeds through a public offering, with warrants over 17.73M shares.
• Mon 28th Sep '26 · Registration: Registered 22.22M shares for sale on Form S-1.
• Thu 10th Sep '26 · Offering filing: NewGenIvf filed to sell up to $6.0M of shares plus register resale shares from convertible-note holders, which could roughly quadruple the share count; the filing flags going-concern risk and notes eight reverse splits since February 2025.
• Thu 10th Sep '26 · Debt restructuring: On August 14, 2026 the company exchanged existing convertible notes for a new $7.1M senior note after it could not satisfy a prior $6.75M obligation in cash, with the new note convertible at a discount to market price.
• Mon 17th Aug '26 · Convertible: Issued a $250K convertible note.